JP2025501740A5 - - Google Patents
Info
- Publication number
- JP2025501740A5 JP2025501740A5 JP2024537378A JP2024537378A JP2025501740A5 JP 2025501740 A5 JP2025501740 A5 JP 2025501740A5 JP 2024537378 A JP2024537378 A JP 2024537378A JP 2024537378 A JP2024537378 A JP 2024537378A JP 2025501740 A5 JP2025501740 A5 JP 2025501740A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- expression cassette
- acid sequence
- nucleic acid
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163291585P | 2021-12-20 | 2021-12-20 | |
| US63/291,585 | 2021-12-20 | ||
| PCT/US2022/081916 WO2023122526A1 (en) | 2021-12-20 | 2022-12-19 | Use of interferon as an adjuvant in vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501740A JP2025501740A (ja) | 2025-01-23 |
| JP2025501740A5 true JP2025501740A5 (https=) | 2025-12-08 |
Family
ID=85221940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537378A Pending JP2025501740A (ja) | 2021-12-20 | 2022-12-19 | ワクチンにおけるアジュバントとしてのインターフェロンの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250057946A1 (https=) |
| EP (1) | EP4452313A1 (https=) |
| JP (1) | JP2025501740A (https=) |
| CN (1) | CN118434443A (https=) |
| AU (1) | AU2022419971A1 (https=) |
| CA (1) | CA3243028A1 (https=) |
| CL (1) | CL2024001831A1 (https=) |
| CO (1) | CO2024007500A2 (https=) |
| CR (1) | CR20240245A (https=) |
| DK (1) | DK202470173A1 (https=) |
| MX (1) | MX2024007696A (https=) |
| WO (1) | WO2023122526A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4208157A1 (en) | 2020-09-04 | 2023-07-12 | Elanco Us Inc. | Palatable formulations |
| DK202370610A1 (en) * | 2022-12-13 | 2024-07-12 | Zoetis Services Llc | Methods of vaccine administration to salmonids |
| CN118956807B (zh) * | 2024-10-17 | 2025-01-24 | 天津赛萌生物技术有限公司 | 一种组蛋白乙酰基转移酶突变体及其在生物大分子制备中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0304634D0 (en) * | 2003-02-28 | 2003-04-02 | Glaxo Group Ltd | Vaccines |
| CA2650730A1 (en) | 2006-04-27 | 2007-11-08 | Pikamab, Inc. | Methods and compositions for antibody therapy |
| GB201013153D0 (en) | 2010-08-04 | 2010-09-22 | Touchlight Genetics Ltd | Primer for production of closed linear DNA |
| WO2014118385A1 (en) * | 2013-02-04 | 2014-08-07 | University of Tromsø | The use of dna sequences encoding an interferon as vaccine adjuvants |
| GB201415789D0 (en) | 2014-09-05 | 2014-10-22 | Touchlight Genetics Ltd | Synthesis of DNA |
| US10456459B2 (en) | 2015-07-20 | 2019-10-29 | Zoetis Services Llc | Liposomal adjuvant compositions |
| CN109844134B (zh) | 2016-08-16 | 2023-05-05 | 塔驰莱特Ip有限公司 | 闭合线性dna的生产 |
| GB201805683D0 (en) | 2018-04-05 | 2018-05-23 | Touchlight Ip Ltd | Reprogramming vectors |
| GB202002068D0 (en) | 2020-02-14 | 2020-04-01 | Touchlight Ip Ltd | DNA synthesis yield improvements |
-
2022
- 2022-12-19 US US18/721,723 patent/US20250057946A1/en active Pending
- 2022-12-19 WO PCT/US2022/081916 patent/WO2023122526A1/en not_active Ceased
- 2022-12-19 AU AU2022419971A patent/AU2022419971A1/en active Pending
- 2022-12-19 EP EP22856944.8A patent/EP4452313A1/en active Pending
- 2022-12-19 JP JP2024537378A patent/JP2025501740A/ja active Pending
- 2022-12-19 CA CA3243028A patent/CA3243028A1/en active Pending
- 2022-12-19 CR CR20240245A patent/CR20240245A/es unknown
- 2022-12-19 CN CN202280084452.5A patent/CN118434443A/zh active Pending
- 2022-12-19 MX MX2024007696A patent/MX2024007696A/es unknown
-
2024
- 2024-06-14 CO CONC2024/0007500A patent/CO2024007500A2/es unknown
- 2024-06-18 CL CL2024001831A patent/CL2024001831A1/es unknown
- 2024-06-19 DK DKPA202470173A patent/DK202470173A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025501740A5 (https=) | ||
| Hogue et al. | Coronavirus structural proteins and virus assembly | |
| Peluso et al. | Polypeptide synthesis in simian virus 5-infected cells | |
| Taylor et al. | Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens | |
| Bosch et al. | Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of Avian influenza viruses | |
| Erles et al. | Isolation and sequence analysis of canine respiratory coronavirus | |
| Macdonald et al. | Identification of the proteins encoded by each genome segment of infectious pancreatic necrosis virus | |
| JPH07506481A (ja) | 組換え豚痘ウイルス | |
| Marín et al. | Virus characterization and sequence of the fusion protein gene cleavage site of recent Newcastle disease virus field isolates from the southeastern United States and Puerto Rico | |
| JP2025503468A5 (https=) | ||
| US20250057946A1 (en) | Use of interferon as an adjuvant in vaccines | |
| US20250127873A1 (en) | Compositions and methods for prevention of piscine myocarditis | |
| Bai et al. | Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses | |
| Kapczynski et al. | Immunization of turkeys with a DNA vaccine expressing either the F or N gene of avian metapneumovirus | |
| Jasmer et al. | Haemonchus contortus GA1 antigens: related, phospholipase C-sensitive, apical gut membrane proteins encoded as a polyprotein and released from the nematode during infection. | |
| Bikel et al. | Proteins of Newcastle disease virus and of the viral nucleocapsid | |
| JP7170783B2 (ja) | 免疫原性組成物、ＳＡＲＳ－ＣｏＶ－２ワクチン、及びベクター | |
| Tsurudome et al. | Identification of regions on the fusion protein of human parainfluenza virus type 2 which are required for haemagglutinin-neuraminidase proteins to promote cell fusion | |
| Ng et al. | Identification of a 24-kDa polypeptide processed from the coronavirus infectious bronchitis virus 1a polyprotein by the 3C-like proteinase and determination of its cleavage sites | |
| Yang et al. | Multivalent DNA vaccine enhanced protection efficacy against infectious bronchitis virus in chickens | |
| Rota et al. | Comparison of the immune response to variant influenza type B hemagglutinins expressed in vaccinia virus | |
| Fukuhara et al. | Mutational analysis of the Sendai virus V protein: importance of the conserved residues for Zn binding, virus pathogenesis, and efficient RNA editing | |
| JP2025503470A5 (https=) | ||
| US20250057937A1 (en) | Compositions and methods for expressing antigens on cell membrane | |
| US20150265699A1 (en) | Recombinant Novirhabdovirus Usable as an Antigen Vector |